Ling Li

22.3k citations
552 papers · 15.0k · 5 hit papers · h-index 58

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Advanced biosensing and bioanalysis techniques
    • Circular RNAs in diseases
    • Metabolism, Diabetes, and Cancer
    • RNA Interference and Gene Delivery

Papers in

    • Metabolism, Diabetes, and Cancer 28
    • Advanced biosensing and bioanalysis techniques 27
    • RNA Interference and Gene Delivery 20
    • Adipokines, Inflammation, and Metabolic Diseases 38

Ling Li

526 papers receiving 14.8k citations

Ling Li's Hit Papers

3D-bioprinted BMSC-laden biomimetic multiphasic scaffolds for efficient repair of osteochondral defects in an osteoarthritic rat model 2021 · 148 citations
1480+8+16Years since publication200400600

Peers

Ling Li
Comparison fields: 5 of 171
  • Cancer Research 2.0k
  • Molecular Biology 6.3k
  • Endocrine and Autonomic Systems 495
  • Aging 117
  • Physiology 1.6k
Replace Yan Chen with:
Yan Chen China
Makoto Suematsu Japan
Chih‐Yang Huang Taiwan
Xiaokun Li China
Athanasios G. Papavassiliou Greece
Emanuela Mazzon Italy
Yan Li China
Shinya Toyokuni Japan
Nobuhiro Yamada Japan
Victor J. Thannickal United States
Ling Li relative to Yan Chen China Yan Chen's profile →
Citations per field
00.5×1.5×
Yan Chen · 1×
Citations per year

Countries citing papers authored by Ling Li

Since Specialization
Citations

This map shows the geographic impact of Ling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Li more than expected).

Fields of papers citing papers by Ling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Li. The network helps show where Ling Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Ling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ling Li Line = papers co-authored together Ling Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 552 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance
Hit paper breakdown →
2020601
2
Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo
Hit paper breakdown →
2001600
3
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Hit paper breakdown →
2009560
4
Rheb promotes cell growth as a component of the insulin/TOR signalling network
Hit paper breakdown →
2003523
5 2014215
6 2021210
7 2015170
8 2005161
9 2000161
10 2007152
11 2012150
12
3D-bioprinted BMSC-laden biomimetic multiphasic scaffolds for efficient repair of osteochondral defects in an osteoarthritic rat model
Hit paper breakdown →
2021148
13 2010130
14 2014126
15 2007123
16 2012121
17 2012105
18 202096
19 201194
20 201494

About Ling Li

Ling Li is a scholar working on Molecular Biology, Epidemiology, Cancer Research, Physiology and Cardiology and Cardiovascular Medicine, having authored 552 papers that have together received 15.0k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (38 papers), Metabolism, Diabetes, and Cancer (28 papers), Adipose Tissue and Metabolism (28 papers), Advanced biosensing and bioanalysis techniques (27 papers), Cancer-related molecular mechanisms research (25 papers), RNA Interference and Gene Delivery (20 papers), Regulation of Appetite and Obesity (19 papers) and MicroRNA in disease regulation (19 papers). The work is most often cited by research in Cancer Research (2.0k citations), Molecular Biology (6.3k citations), Endocrine and Autonomic Systems (495 citations), Aging (117 citations) and Physiology (1.6k citations). Ling Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Gangyi Yang, Mengliu Yang, Hua Liu, Guenther Boden, Bruce A. Edgar, Geneviève Renier, Xinsheng Gao, Leslie Saucedo, Harald Vaessin and Jingqiu Cheng. Their work appears in journals such as Scientific Reports, Oncotarget, Frontiers in Endocrinology, PLoS ONE and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact